Sandra M Petralia, Alicia A Walf, Cheryl A Frye
Index: Neuroendocrinology 84(6) , 405-14, (2006)
Full Text: HTML
Progestin-facilitated lordosis of hamsters and rats is enhanced by activation of dopamine type 1 (D1) or GABAA/benzodiazepine receptor complexes (GBRs) in the ventral tegmental area (VTA) and these effects involve G-proteins and second messengers, such as adenosine 3',5'-monophosphate (cAMP). We examined whether D1- and/or GBR-mediated increases in progestin-facilitated lordosis of female hamsters and rats involve the cAMP-dependent protein kinase, protein kinase A (PKA), in the VTA. In experiment 1, ovariectomized hamsters, primed with estradiol (E2; 10 microg at h 0) + progesterone (P; 100 microg at h 45), were first pre-tested for lordosis and motor behavior (h 48) and then infused with the PKA inhibitor, Rp-cAMP (100 ng/side), or vehicle. Thirty minutes later, hamsters were retested and then received infusions of the D1 agonist, SKF38393 (100 ng/side), the GBR agonist, muscimol (100 ng/side), or vehicle to the VTA. Hamsters were post-tested for lordosis and motor behavior 30 min later. In Experiment 2, ovariectomized rats, primed with E2 (10 microg at h 0), were first pre-tested for lordosis and then infused with Rp-cAMP (100 ng/side) or vehicle to the VTA at h 44. Immediately after testing, rats received infusions of SKF38393 (100 ng/side), muscimol (100 ng/side), or vehicle and were retested for lordosis. Rats were then infused with the neurosteroid, 5alpha-pregnan-3alpha-ol-20-one (3alpha,5alpha-THP; 100 or 200 ng/side), or beta-cyclodextrin vehicle and were post-tested for lordosis and motor behavior 10 and 60 min later. The enhancing effects of progestins or progestins plus D1 or GBR activation on lordosis of E2-primed hamsters and rats were blocked by the PKA inhibitor, Rp-cAMP. Thus, in the VTA, progestins' membrane actions involving D1 or GBRs are mediated, in part, by PKA.Copyright 2007 S. Karger AG, Basel.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Tetrahydro-11-deoxy Cortisol
CAS:68-60-0 |
C21H34O4 |
Study of urinary steroid hormone disorders: difference betwe...
2014-07-01 [Anal. Bioanal. Chem 406(18) , 4325-35, (2014)] |
[Urinary tetrahydro-11-deoxycortisol].
2010-07-01 [Nihon Rinsho. 68 Suppl 7 , 401-3, (2010)] |
A quantitative in vivo mouse model used to assay inhibitors ...
1991-02-15 [Cancer Res. 51(4) , 1339-44, (1991)] |
Potent inhibitory effects of steroids in an in vitro model o...
1996-09-01 [J. Endocrinol. 150(3) , 457-64, (1996)] |
Comprehensive study of urinary cortisol metabolites in hyper...
2006-01-01 [Clin. Endocrinol. (Oxf.) 64(1) , 37-45, (2006)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved